Survival and plasticity of basal forebrain cholinergic systems in mice transgenic for presenilin-I and amyloid precursor protein mutant genes

NeuroReport

Volumn 12, Issue 7, 2001, Pages 1377-1384

  Hernandez, Dena ^a   Sugaya, Kiminobu ^a   Qu, Tingyu ^a   McGowan, Eileen ^a   Duff, Karen ^b   McKinney, Michael ^a  

^a MAYO CLINIC   (United States)

^b NEW YORK UNIVERSITY   (United States)

Author keywords

Acetylcholine; Alzheimer's disease; Basal forebrain

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; AMYLOID PRECURSOR PROTEIN; CHOLINERGIC RECEPTOR; MESSENGER RNA; MUTANT PROTEIN; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CHOLINERGIC SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; FOREBRAIN; GENE EXPRESSION; GENE MUTATION; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR BINDING; SURVIVAL; TRANSGENE; TRANSGENIC MOUSE;

EID: 0035947141     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200105250-00018     Document Type: Article

References (30)

1. Koh JY, Yang LL, Cotman CW et al. Brain Res 533, 315-320 (1990).
2. Pike CJ, Burdick D, Walencewicz AJ et al. J Neurosci 13, 1676-1687 (1993).
3. Loo DT, Copani A, Pike CJ et al. Proc Natl Acad Sci USA 90, 7951-7955 (1993).
4. Whitehouse PJ, Price DL, Struble RG et al. Science 215, 1237-1239 (1982).
5. Bowden DM, Smith CB, White P et al. Brain 99, 459-496 (1976).
6. Davies P and Maloney AJF. Lancet 2, 1403 (1976).
7. Coyle JT, Price DL, and DeLong MR. Science 219, 1184-1190 (1983).
8. McKinney M and Coyle JT. Mayo Clin Proc 66, 1225-1237 (1991).
9. Hardy J. Trends Neurosci 20, 154-159 (1997).
10. Sherrington R, Rogaev EI, Liang Y et al. Nature 375, 754-760 (1995).
11. Levy-Lehad E, Wijsman EM, Nemens E et al. Science 269, 973-977 (1995).
12. Hsiao K, Chapman P, Nilsen S et al. Science 274, 99-102 (1996).
13. Irizarrv MC, McNamara M, Fedorchak K et al. J Neuropathol Exp Neurol 56, 965-973 (1997).
14. Duff K, Eckman C, Zehr C et al. Nature 383, 710-713 (1996).
15. McGowan E, Sanders S, Iwatsubo T et al. Neurobiol Dis 6, 231-244 (1999).
16. Holcomb L, Gordon MN, McGowan E et al. Nature Med 4, 97-100 (1998).
17. Takeuchi A, Irizarry MC, Duff K et al. Am J Pathol 157, 331-339 (2000)
18. Wong TP, Bebeir T, Duff K et al. J Neurosci 19, 2706-2716 (1999).
19. McKinney M, Coyle JT, and Hedreen J. J Comp Neurol 217, 103-121 (1983).
20. Schrier BK and Schuster L. J Neurochem 14, 977-985 (1967).
21. Johnston MV, McKinney M and Coyle JT. Proc Natl Acad Sci USA 76, 5392-5396 (1979).
22. Sugaya K, Chouinard M, Greene R et al. J Neurosci 16, 3427-3443 (1996).
23. Frautschy SA, Horn DL, Sigel JJ et al. J Neurosci 18, 8311-8321 (1998).
24. Smith MA, Hirai K, Hsiao K et al. J Neurochem 70, 2212-2215 (1998).
25. Mattson MP and Pedersen WA. Int J Dev Neurosci 16, 737-753 (1998).
26. Mucke L, Masliah E, Johnson WB et al. Brain Res, 666, 151-167 (1994).
27. Phinney AL, Deller T, Stalder M et al. J Neurosci 19, 8552-8559 (1999)
28. Wittenburg N, Eimer S, Lakowski B et al. Nature 406, 306-309 (2000).
29. Cuello AC, Maysinger D, and Garofalo L. Mol Neurobiol 6, 451-461 (1992).
30. Hughes PE, Alzexi T, Walton M et al. Prog Neurobiol 57, 421-450 (1999).